Discontinued — last reported Q4 '23
Business Segments · Goodwill, Impairment Loss
Covance Drug Development — Goodwill, Impairment Loss
Labcorp Holdings Covance Drug Development — Goodwill, Impairment Loss remained flat by 0.0% to $83.40M in Q4 2023 compared to the prior quarter. Year-over-year, this metric grew by 28.3%, from $65.00M to $83.40M. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryProfitability
SignalLower is better
VolatilityVolatile
First reportedQ1 2019
Last reportedQ4 2023
Rolls up toGoodwill impairment
How to read this metric
A significant loss signals poor acquisition performance or deteriorating market conditions for drug development services.
Detailed definition
A non-cash charge recognized when the carrying amount of goodwill in the drug development segment exceeds its implied fa...
Peer comparison
A negative indicator often seen across all sectors during economic downturns or strategic shifts.
Metric ID:
lh_segment_covance_drug_development_goodwill_impairment_lossHistorical Data
8 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | |
|---|---|---|---|---|---|---|---|---|
| Value | $65.00M | $65.00M | $65.00M | $65.00M | $83.40M | $83.40M | $83.40M | $83.40M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +28.3% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | +28.3% | +28.3% | +28.3% | +28.3% |
Range$65.00M – $83.40M
CAGR+15.3%
Avg YoY Growth+28.3%
Median YoY Growth+28.3%
Current Streak7+ quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Labcorp Holdings's covance drug development — goodwill, impairment loss?
- Labcorp Holdings (LH) reported covance drug development — goodwill, impairment loss of $83.40M in Q4 2023.
- How has Labcorp Holdings's covance drug development — goodwill, impairment loss changed year-over-year?
- Labcorp Holdings's covance drug development — goodwill, impairment loss increased by 28.3% year-over-year, from $65.00M to $83.40M.
- What does covance drug development — goodwill, impairment loss mean?
- A reduction in the value of goodwill due to the segment's underperformance.